Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eylea
Eylea
Eylea casts a shadow over Novartis' latest approval
Biopharma Dive
Wed, 10/9/19 - 11:04 pm
Novartis
Beovu
wet age-related macular degeneration
Regeneron
Eylea
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Pharmaforum
Tue, 10/8/19 - 09:27 am
Novartis
brolucizumab
Bayer
Eylea
wet age-related macular degeneration
FDA
Novartis backs brolucizumab with new head-to-head Eylea trial
Pharmaforum
Mon, 09/9/19 - 08:15 pm
Novartis
clinical trials
brolucizumab
Eylea
Bayer
Regeneron
age-related macular degeneration
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Amgen
AMG 510
KRAS inhibitors
Roche
PTC Therapeutics
risdiplam
Eylea
Novartis
What happened a year ago this week in biopharma? August 12-18, 2018
Mon, 08/19/19 - 11:04 am
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Regeneron gets FDA approval for Eylea injection prefilled syringe
Ophthalmology Times
Tue, 08/13/19 - 10:34 am
Regeneron
Eylea
FDA
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Tue, 05/14/19 - 09:58 am
Regeneron
Eylea
diabetic retinopathy
FDA
Bayer
With Bayer predicting slowdowns for Xarelto and Eylea, what will fill the gap?
Fierce Pharma
Wed, 02/27/19 - 07:15 pm
Bayer
Xarelto
Eylea
Regeneron touts one-year diabetic retinopathy data for Eylea
Drug Delivery Business News
Mon, 02/11/19 - 11:44 pm
Regeneron
Eylea
proliferative diabetic retinopathy
Roche expands its PhIII program for Eylea rival as long-acting data back its blockbuster contender faricimab
Endpoints
Mon, 10/29/18 - 10:27 am
Roche
Genentech
Regeneron
Novartis
Eylea
faricimab
wet-AMD
Regeneron and Roche Duke it Out in the Diabetic Retinopathy Market
BioSpace
Thu, 10/25/18 - 11:43 am
Regeneron
Eylea
diabetic retinopathy
Roche
Lucentis
FDA kicks Regeneron’s latest Eylea application to the curb, but they’re not sweating it
Endpoints
Thu, 10/25/18 - 09:56 am
Regeneron
FDA
Eylea
complete response letter
FDA to review Regeneron’s Eylea for diabetic retinopathy
Drug Delivery Business News
Thu, 09/13/18 - 11:29 pm
Regeneron
FDA
Eylea
diabetic retinopathy
Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack
Endpoints
Fri, 08/17/18 - 09:28 am
FDA
Eylea
Regeneron
Novartis
wet age-related macular degeneration
Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line
Endpoints
Mon, 08/13/18 - 11:39 am
Regeneron
Eylea
Novartis
RTH258
wet age-related macular degeneration
FDA
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
Sun, 08/5/18 - 07:25 pm
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
Regeneron plots DTC advertising and discount push to put Eylea back on track
Fierce Pharma
Fri, 08/3/18 - 11:08 pm
Regeneron
Sanofi
Eylea
DTC advertising
Allergan’s eye contender cannot knock Eylea off its perch
EP Vantage
Sun, 07/22/18 - 12:24 pm
Regeneron
Eylea
wet age-related macular degeneration
Allergan
molecular
abicipar
Regeneron Focuses on Expanding Eylea’s Diabetic Retinopathy Label
Market Realist
Thu, 06/21/18 - 09:38 am
Regeneron
FDA
Eylea
diabetic retinopathy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »